NCT00465569View on ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Milk Hypersensitivity

Interventions

DRUG

cow's milk powder

Milk powder given orally in escalating doses to a goal of 500 mg for approximately 23 weeks

OTHER

Placebo

Trial Locations (2)

21287

The Johns Hopkins Hospital, Baltimore

27710

Duke University, Durham

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

lead

Johns Hopkins University

OTHER